Cargando…
New Pharmacological Perspectives for the Leptin Receptor in the Treatment of Obesity
After its discovery in 1994, leptin became the great hope as an anti-obesity treatment based on its ability to reduce food intake and increase energy expenditure. However, treating obese people with exogenous leptin was unsuccessful in most cases since most of them present already high circulating l...
Autores principales: | Roujeau, Clara, Jockers, Ralf, Dam, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195360/ https://www.ncbi.nlm.nih.gov/pubmed/25352831 http://dx.doi.org/10.3389/fendo.2014.00167 |
Ejemplares similares
-
Comment on “The Use of BRET to Study Receptor-Protein Interactions”
por: Jockers, Ralf
Publicado: (2014) -
Frontiers Commentary on Tallet et al. Investigation of Prolactin Receptor Activation and Blockade Using Time-Resolved Fluorescence Resonance Energy Transfer
por: Jockers, Ralf
Publicado: (2014) -
Possible Pharmacological Approach Targeting Endoplasmic Reticulum Stress to Ameliorate Leptin Resistance in Obesity
por: Hosoi, Toru, et al.
Publicado: (2016) -
Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling
por: Vauthier, Virginie, et al.
Publicado: (2016) -
Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity
por: Altirriba, Jordi, et al.
Publicado: (2015)